Publications scientifiques Bordet

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.
Auteurs Schoenauen L, Stubbe FX, Van Gestel D, Penninckx S, Heuskin AC
Auteurs (entité) Penninckx Sébastien
Revue Clin Transl Radiat Oncol
Date de publication 2024-03

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.
Auteurs Schoenauen L, Stubbe FX, Van Gestel D, Penninckx S, Heuskin AC
Auteurs (entité) VAN GESTEL DIRK
Revue Clin Transl Radiat Oncol
Date de publication 2024-03

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) VEYS ISABELLE
Revue Breast Cancer Res Treat
Date de publication 2024-01

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) LIBERALE GABRIEL
Revue Breast Cancer Res Treat
Date de publication 2024-01

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) LARSIMONT DENIS
Revue Breast Cancer Res Treat
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) DELEU ANNE-LEEN
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) PICCART MARTINE
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) FLAMEN PATRICK
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) GEBHART GERALDINE
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Publications scientifiques d'Erasmus

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Publications scientifiques de l'Hôpital pour enfants Reine Fabiola

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Publications scientifiques de Jules Bordet

Publications scientifiques Bordet

Publications scientifiques Bordet

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Hôpital Erasme

Hôpital pédiatrique Reine Fabiola

Institut Jules Bordet

Publications scientifiques Bordet

Publications scientifiques Bordet

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Hôpital Erasme

Hôpital pédiatrique Reine Fabiola

Institut Jules Bordet

Rechercher un mot-clé

Veuillez choisir un hôpital